<p>Lars Fruergaard Jørgensen, CEO of the company which makes game-changing obesity drugs Ozempic and Wegovy, explains how its culture and long-view underpin its recent turnaround.</p>

Lars Fruergaard Jørgensen, CEO of the company which makes game-changing obesity drugs Ozempic and Wegovy, explains how its culture and long-view underpin its recent turnaround.

Why Novo Nordisk’s CEO has learned to trust his gut feeling

As President of the International Institute for Management Development - better known as IMD - Jean-François Manzoni has a direct line to some of the world’s most interesting and successful business leaders. In this new podcast, he shares that opportunity with you.In each episode, we’ll hear from a different CEO about the path that brought them to the C-suite, the insights they’ve gained at the top -- and the advice they’d like to pass on to the next generation.New episodes every other Thursday.

Share Why Novo Nordisk’s CEO has learned to trust his gut feeling

Sign up to save your podcasts

Why Novo Nordisk’s CEO has learned to trust his gut feeling

Why Novo Nordisk’s CEO has learned to trust his gut feeling

More shows like The CEO Dialogue

Management Under The Microscope

I by IMD

ManagementCast by IMD